Approval · Notice of Compliance 1716 · 2003
THRIPHASIL 21: Notice of Compliance 1716
Issued April 7, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1716
- Date
- April 7, 2003
- Company
- Wyeth CanadaSt. Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Oral contraceptive
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| THRIPHASIL 21 | 02043726 | Cancelled Post Market |
| TRIPHASIL 28 | 02043734 | Cancelled Post Market |
Medicinal ingredients
- ETHINYL ESTRADIOL 30 MCG per TAB
- LEVONORGESTREL 50 MCG per TAB
- ETHINYL ESTRADIOL 40 MCG per TAB
- LEVONORGESTREL 75 MCG per TAB
- LEVONORGESTREL 125 MCG per TAB